Quick Answer
Evolent Health, Inc. reported Total Revenue of $1.88 billion for fiscal year 2025.
Evolent Health, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.88B -26.6% |
$2.55B +30.1% |
$1.96B +45.3% |
$1.35B +48.9% |
$907.96M -1.8% |
$924.64M +34.6% |
| Revenue (ASC 606) | $1.88B -26.6% |
$2.55B +30.1% |
$1.96B +45.3% |
$1.35B +48.9% |
$907.96M -1.8% |
$924.64M +9.2% |
| Net Income | -$534.51M -767.4% |
-$61.62M +45.5% |
-$113.04M -489.9% |
-$19.16M +49.0% |
-$37.60M +88.8% |
-$334.25M -10.7% |
| Diluted EPS | -$5.07 -525.9% |
-$0.81 +36.7% |
-$1.28 -540.0% |
-$0.20 +54.5% |
-$0.44 +88.8% |
-$3.94 -7.4% |
| Total Assets | $1.90B -25.4% |
$2.54B -5.1% |
$2.68B +47.5% |
$1.82B +28.0% |
$1.42B +3.5% |
$1.37B -8.4% |
| Cash and Equivalents | $151.86M +45.7% |
$104.20M -46.0% |
$192.82M +2.5% |
$188.20M -29.3% |
$266.28M -16.5% |
$319.00M +215.8% |
| Long-Term Debt | $970.54M +97.9% |
$490.52M -17.8% |
$597.05M +44.6% |
$412.99M +91.5% |
$215.68M -18.1% |
$263.34M -10.3% |
| Stockholders Equity | $415.19M -58.5% |
$1.00B -6.2% |
$1.07B +24.2% |
$859.42M +23.9% |
$693.63M +11.9% |
$619.60M -33.3% |
| Operating Income | -$410.14M -913.1% |
-$40.48M +43.1% |
-$71.21M -2055.3% |
$3.64M +108.6% |
-$42.41M +83.9% |
-$262.85M +14.9% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $479.53M | -22.8% | +7.9% |
| Revenue (ASC 606) | September 30, 2025 | $479.53M | -22.8% | +7.9% |
| Net Income | September 30, 2025 | -$20.86M | +9.8% | -4.9% |
| Diluted EPS | September 30, 2025 | -$0.24 | +11.1% | +45.5% |
| Total Assets | September 30, 2025 | $2.45B | -1.9% | -0.3% |
| Cash and Equivalents | September 30, 2025 | $116.65M | +20.8% | -22.7% |
| Long-Term Debt | September 30, 2025 | $1.05B | +75.9% | +62.7% |
| Stockholders Equity | September 30, 2025 | $842.23M | -18.9% | -6.0% |
| Operating Income | September 30, 2025 | $886.0K | +105.4% | +175.7% |
| Shares Outstanding | June 30, 2020 | 85.46M | — | +0.0% |
- Evolent Health, Inc. reported Total Revenue of $1.88 billion for fiscal year 2025.
- Evolent Health, Inc. showed a decrease of -26.6% in Total Revenue compared to the prior fiscal year.
- Evolent Health, Inc. reported Revenue (ASC 606) of $1.88 billion for fiscal year 2025.
- Evolent Health, Inc. showed a decrease of -26.6% in Revenue (ASC 606) compared to the prior fiscal year.
- Evolent Health, Inc. reported Net Income of -$534.51 million for fiscal year 2025.
- Evolent Health, Inc. showed a decrease of -767.4% in Net Income compared to the prior fiscal year.
- Evolent Health, Inc. reported Diluted EPS of $5.07 per share (loss) for fiscal year 2025.
- Evolent Health, Inc. showed a decrease of -525.9% in Diluted EPS compared to the prior fiscal year.
- Evolent Health, Inc. reported Total Assets of $1.90 billion for fiscal year 2025.
- Evolent Health, Inc. showed a decrease of -25.4% in Total Assets compared to the prior fiscal year.
- Evolent Health, Inc. reported Cash and Equivalents of $151.86 million for fiscal year 2025.
- Evolent Health, Inc. showed an increase of +45.7% in Cash and Equivalents compared to the prior fiscal year.
- Evolent Health, Inc. reported Long-Term Debt of $970.54 million for fiscal year 2025.
- Evolent Health, Inc. showed an increase of +97.9% in Long-Term Debt compared to the prior fiscal year.
- Evolent Health, Inc. reported Stockholders Equity of $415.19 million for fiscal year 2025.
- Evolent Health, Inc. showed a decrease of -58.5% in Stockholders Equity compared to the prior fiscal year.
- Evolent Health, Inc. reported Operating Income of -$410.14 million for fiscal year 2025.
- Evolent Health, Inc. showed a decrease of -913.1% in Operating Income compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: